Asianet Newsable on MSN

India's Suryastra rocket launcher completes successful Odisha trials

Pune-based Nibe Limited successfully test-fired its Suryastra Universal Rocket Launcher in Odisha. The trials, following an ...
CNBCTV18

Nibe Limited successfully tests 150 km, 300 km Suryastra rockets in Odisha I Watch

Nibe Limited tests Suryastra rockets in Chandipur, boosting Indian Army precision strike capability with successful 150 km ...
Medscape

Will ROCKET Trials Put Atopic Dermatitis on New Trajectory?

PARIS — The anti-OX40 monoclonal antibody rocatinlimab produced clinically meaningful improvements in adults with moderate-to-severe atopic dermatitis both as monotherapy and when used with topical ...
Hosted on MSN

Rocket to relaunch rare disease trial after FDA approval

The US Food and Drug Administration (FDA) has given Rocket Pharmaceuticals approval to continue its pivotal Phase II trial of gene therapy RP-A501 in Danon disease. This follows the regulator’s ...
CNBC

Rocket Pharma's shares soar after U.S. FDA lets gene therapy trial resume

The U.S. health regulator has allowed a study of Rocket Pharmaceuticals' gene therapy to resume, less than three months after halting it following a patient's death. The drugmaker's shares soared over ...